Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia
Eric J. Sigler, John C. Randolph…Volume:
251
Language:
english
DOI:
10.1007/s00417-012-2150-1
Date:
April, 2013
File:
PDF, 236 KB
english, 2013